Health Reporter French Polynesia: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Reporter French Polynesia.

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

Press releases published on December 15, 2025

December 15, 2025

3D Systems Announces FDA 510(k) Clearance Expanding VSP Orthopedics Indications to Include Skeletally Mature Adolescents

GlobeNewswire

December 15, 2025

Quipt Home Medical Reports Fourth Quarter and Fiscal Year 2025 Financial Results

GlobeNewswire

December 15, 2025

Medicus Pharma Ltd. Completes Enrolment of Ninety (90) Patients for Phase 2 Clinical Study (SKNJCT-003) to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin

GlobeNewswire

December 15, 2025

Abeona Therapeutics® Announces Appointment of Mohamad Tabrizi as Chief Business Officer

GlobeNewswire

December 15, 2025

Tiziana Life Sciences Announces Withdrawal of Proposed Public Offering

GlobeNewswire

December 15, 2025

Quipt Home Medical Enters Into Definitive Agreement for Its Acquisition by Affiliates of Kingswood Capital Management and Forager Capital Management

GlobeNewswire

December 15, 2025

Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study

GlobeNewswire

December 15, 2025

Claire’s Place Foundation Steps Up for Cystic Fibrosis Community in a Year Marked by Wildfires & Rising Costs

GlobeNewswire

December 15, 2025

Dyadic Applied BioSolutions Establishes Commercial Partnership to Accelerate Adoption of Dyadic’s Recombinant Growth Factors and Media Proteins

GlobeNewswire

December 15, 2025

Zenas BioPharma’s Partner, InnoCare Pharma, Announces Achievement of Primary Endpoint in Phase 2b Study of Orelabrutinib, a BTK Inhibitor, for Systemic Lupus Erythematosus

GlobeNewswire

December 15, 2025

Kraig Biocraft Laboratories Successfully Completes Production Cycle, Delivering Over One Million BAM-1 Alpha Hybrid Eggs for Deployment

GlobeNewswire

December 15, 2025

Radiopharm Theranostics Achieves Primary Endpoint in 92% of Patients at Interim Analysis of RAD 101 Phase 2b Imaging Trial in Brain Metastases

GlobeNewswire

December 15, 2025

Jade Biosciences Announces $45 Million Private Placement

GlobeNewswire

December 15, 2025

Roxadustat Granted Orphan Drug Designation for the Treatment of Myelodysplastic Syndromes by the U.S. Food and Drug Administration

GlobeNewswire

December 15, 2025

Abpro Holdings Announces Submission of an IND Application to Initiate a Phase 1 Clinical Trial of T cell engager ABP-102/CT-P72 for HER2-positive Cancers

GlobeNewswire

December 15, 2025

Kyverna Therapeutics Announces Positive Topline Data from Registrational KYSA-8 Trial of Miv-cel (KYV-101) in Stiff Person Syndrome

GlobeNewswire

December 15, 2025

Palvella Therapeutics Announces Positive Topline Results from Phase 2 TOIVA Clinical Trial of QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) for the Treatment of Cutaneous Venous Malformations, a Serious, Rare Genetic Disease with No…

GlobeNewswire

December 15, 2025

Greenwich LifeSciences Announces Preliminary Analysis Showing 80% Recurrence Rate Reduction in the Open Label Arm of FLAMINGO-01

GlobeNewswire

December 15, 2025

NANOBIOTIX to Join CAC Mid 60 and SBF 120 Indices on Euronext Paris

GlobeNewswire

December 15, 2025

NANOBIOTIX va intégrer les indices CAC Mid 60 et SBF 120 d’Euronext Paris

GlobeNewswire